James Angus Duncan Smith serves as Executive at GENELABS TECHNOLOGIES INC /CA, where they oversee executive responsibilities. Since joining the company, James Angus Duncan Smith has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 31, 2007 involved transacting 4,552 shares valued at $5.1K.
James Angus Duncan Smith currently holds 48,157 shares of GENELABS TECHNOLOGIES INC /CA (GNLBD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Angus Duncan Smith has been a net neutral trader of GNLBD stock. They have purchased $0 and sold $0 worth of shares.
James Angus Duncan Smith's most recent insider trade was on Dec 31, 2007, when they sold 4,552 shares at $1.11 per share.
Get notified when new Form 4 filings are submitted
| $1.24 |
| Discretionary |
| Dec 29, 2006 | GNLB | $8.4K | Other | 6,928 | $1.21 | Discretionary |
| Jun 30, 2006 | GNLB | $2.8K | Other | 2,414 | $1.17 | Discretionary |
| Dec 30, 2005 | GNLBD | $2 | Other | 1 | $1.58 | Discretionary |